NO171827C - Fremgangsmaate ved fremstilling av en tilberedning for retardert utskillelse av teofyllin - Google Patents

Fremgangsmaate ved fremstilling av en tilberedning for retardert utskillelse av teofyllin

Info

Publication number
NO171827C
NO171827C NO855215A NO855215A NO171827C NO 171827 C NO171827 C NO 171827C NO 855215 A NO855215 A NO 855215A NO 855215 A NO855215 A NO 855215A NO 171827 C NO171827 C NO 171827C
Authority
NO
Norway
Prior art keywords
theophylline
retarded
preparing
separation
preparation
Prior art date
Application number
NO855215A
Other languages
English (en)
Norwegian (no)
Other versions
NO171827B (no
NO855215L (no
Inventor
Gerald Benedik
Volker Steinijans
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO855215L publication Critical patent/NO855215L/no
Publication of NO171827B publication Critical patent/NO171827B/no
Publication of NO171827C publication Critical patent/NO171827C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
NO855215A 1984-12-21 1985-12-20 Fremgangsmaate ved fremstilling av en tilberedning for retardert utskillelse av teofyllin NO171827C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH268385 1985-06-24

Publications (3)

Publication Number Publication Date
NO855215L NO855215L (no) 1986-06-23
NO171827B NO171827B (no) 1993-02-01
NO171827C true NO171827C (no) 1993-05-12

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855215A NO171827C (no) 1984-12-21 1985-12-20 Fremgangsmaate ved fremstilling av en tilberedning for retardert utskillelse av teofyllin

Country Status (20)

Country Link
US (1) US4803080A (fr)
EP (1) EP0185331B1 (fr)
KR (1) KR920006910B1 (fr)
CN (1) CN1008060B (fr)
AU (1) AU581274B2 (fr)
BG (1) BG60833B2 (fr)
CA (1) CA1261268A (fr)
CS (1) CS396391A3 (fr)
DE (1) DE3572924D1 (fr)
DK (1) DK164843C (fr)
ES (1) ES8704079A1 (fr)
FI (1) FI84782C (fr)
GR (1) GR853051B (fr)
HU (1) HU193359B (fr)
IE (1) IE58246B1 (fr)
IL (1) IL77322A (fr)
NO (1) NO171827C (fr)
NZ (1) NZ214534A (fr)
PT (1) PT81714B (fr)
SK (1) SK278868B6 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (fr) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Forme de dosage de la tétracycline
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
AU2005325930B2 (en) * 2005-01-27 2012-01-19 Alembic Limited Extended release formulation of Levetiracetam
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
JP6158801B2 (ja) 2011-07-15 2017-07-05 ニューサート サイエンシーズ， インコーポレイテッド 代謝経路を変調させるための組成物および方法
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
AU2014207707B2 (en) 2013-01-15 2018-11-01 Nusirt Sciences, Inc. Treating pulmonary conditions
AU2014236687A1 (en) 2013-03-15 2015-09-10 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
CA2939833A1 (fr) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions et procedes permettant la reduction ou la prevention de steatose hepatique
EP3284795B1 (fr) * 2015-04-16 2023-08-02 The School Corporation Kansai University Utilisation d'un polymère contenant une base purique comme activateur anti-glaciogène
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (fr) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Inhibition spécifique de la janus kinase 3 (jak3) pour moduler des réponses immunitaires antitumorales
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
EP0083372B1 (fr) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Theophylline a liberation prolongee
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DE3572924D1 (en) 1989-10-19
KR920006910B1 (ko) 1992-08-22
PT81714A (de) 1986-01-01
BG60833B2 (bg) 1996-04-30
IL77322A (en) 1990-07-12
SK278868B6 (sk) 1998-04-08
NO171827B (no) 1993-02-01
CS396391A3 (en) 1992-06-17
ES8704079A1 (es) 1987-04-01
PT81714B (pt) 1988-04-21
IE58246B1 (en) 1993-08-11
AU5161885A (en) 1986-07-17
DK164843C (da) 1993-01-11
KR860004634A (ko) 1986-07-11
ES550291A0 (es) 1987-04-01
CN85109688A (zh) 1986-06-10
US4803080A (en) 1989-02-07
FI84782C (fi) 1992-01-27
NZ214534A (en) 1988-08-30
CN1008060B (zh) 1990-05-23
GR853051B (fr) 1986-02-03
CA1261268A (fr) 1989-09-26
FI854973A0 (fi) 1985-12-16
DK600485D0 (da) 1985-12-20
DK164843B (da) 1992-08-31
AU581274B2 (en) 1989-02-16
NO855215L (no) 1986-06-23
FI854973A (fi) 1986-06-22
HU193359B (en) 1987-09-28
EP0185331A1 (fr) 1986-06-25
HUT40334A (en) 1986-12-28
IE853107L (en) 1986-06-21
EP0185331B1 (fr) 1989-09-13
FI84782B (fi) 1991-10-15
DK600485A (da) 1986-06-22

Similar Documents

Publication Publication Date Title
NO171827C (no) Fremgangsmaate ved fremstilling av en tilberedning for retardert utskillelse av teofyllin
DE3568442D1 (en) A method of preparation of droplets
HU900750D0 (en) Process for preparation of phenyl-hydrazine-derivatives
NO174604C (no) Fremgangsmåte ved fremstilling av relief-former
YU181285A (en) Process for preparation of sylibinine without izosylibinine
CS826081A2 (en) Method of tetrasubstituted benzene derivatives preparation
BG44204A3 (en) Method for preparing of 2- oxyindol derivatives
BG45698A3 (en) Method for preparing of dimethyltherephthalate
IL82190A0 (en) Method of preparing a polyvinyl-pyrrolidone-halogen complex of improved stability
EP0223513A3 (en) A process for preparation of cyclopolydiorganosiloxanes
ZA879331B (en) Method for preparation of mercaptobenzoates
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
NO840433L (no) Fremgangsmaate ved fremstilling av mitomicinanaloger
PT72320A (en) Process for preparation of a furan derivative
CS369187A2 (en) Process for preparing derivatives of 3-/hydroxymethyl/-isoquinoline
AR243500A1 (es) Procedimiento para preparar compuestos de mercaptobenzoato.
YU63685A (en) Process for preparation derivatives of cephalosporine
RO83972A (fr) Proc5de de preparation des derives d'oxazaphosphines
BG46524A1 (en) Method for preparing of cinnamon aldehyde
YU43570B (en) Process for preparation of derivatives of d()alpha-amino-benzile-penicilyns
GR861974B (en) Process forthe preparation of alkyl 2-carboalkoxy-3,4-dialkoxybenzenecarbamates
BG42929A1 (en) Method for manufacture of polystyrene resistant to shock
RO91177A2 (fr) Procede de preparation de (z)-6-heneicosen-yl-one
GB2164647B (en) Process for the preparation of a furan derivative
CS646689A2 (en) Method of ceramic filter preparation

Legal Events

Date Code Title Description
MK1K Patent expired